MedPath

The evaluation of effectiveness of Cydonia oblonga syrup on clinical symptoms in patients with Gastroesophageal reflux disease

Not Applicable
Conditions
Pediatric gastro-oesophageal reflux disease.
Gastro-oesophageal reflux disease without oesophagitis
Registration Number
IRCT2015030921388N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

children more than one month and less than 18 years old; signed an informed consent form by parents; Vomiting immediately after eating; restlessness for one to three hours after feeding; respiratory distress after feeding; the lack of weight gain; refusing to eat; endoscopically proven gasteroeshophageal reflux disease.

Exclusion criteria: Children younger than 1 month and older than 18 years old; those who need to use other oral or intravenous drugs; unwillingness to continue to participate in the study; sensitivity to study drugs; patients with other gasteroeshophageal disorders such as esophagitis and peptic ulcer; patients with active renal, liver and neurological diseases; mental retardation; pregnancy; lactation and disability of parents/guardian to cooperate in filling the forms (cognitive or language disorder).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath